CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 25,093 shares (option exercise)
- 4 Planned sale SVP, Finance & CAO sold 1,199 shares at $1.31 ($1,571)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 50,188 shares (option exercise)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,235 shares at $2.02 ($2,495)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,191 shares at an average $8.18 ($9,741)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, R&D AND CSO sold 129,206 shares at an average $7.65 ($988,495)
- 4 Open-market sale EVP, R&D AND CSO sold 41,783 shares at an average $6.93 ($289,492)
- 4 Open-market sale EVP, R&D AND CSO sold 50,000 shares at $7.13 ($356,500)
- 4 Open-market sale EVP, R&D AND CSO sold 92,377 shares at an average $7.04 ($650,563)
- 4 Open-market sale EVP, R&D AND CSO sold 105,931 shares at an average $6.95 ($736,500)
Page 3 of 6 · 119 filings